<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>21</CFRTITLE>
    <CFRTITLETEXT>Food and Drugs</CFRTITLETEXT>
    <VOL>5</VOL>
    <DATE>2018-04-01</DATE>
    <ORIGINALDATE>2018-04-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Acne active ingredients.</TITLE>
    <GRANULENUM>Â§ 333.310</GRANULENUM>
    <HEADING>Section Â§ 333.310</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 21" SEQ="4">Food and Drugs</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="3">FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)</PARENT>
      <PARENT HEADING="SUBCHAPTER D" SEQ="2">DRUGS FOR HUMAN USE</PARENT>
      <PARENT HEADING="PART 333" SEQ="1">TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE</PARENT>
      <PARENT HEADING="Subpart D" SEQ="0">Topical Acne Drug Products</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 333.310</SECTNO>
    <SUBJECT>Acne active ingredients.</SUBJECT>
    <P>The active ingredient of the product consists of any of the following:</P>
    <P>(a) Benzoyl peroxide, 2.5 to 10 percent.</P>
    <P>(b) Resorcinol, 2 percent, when combined with sulfur in accordance with § 333.320(a).</P>
    <P>(c) Resorcinol monoacetate, 3 percent, when combined with sulfur in accordance with § 333.320(b).</P>
    <P>(d) Salicylic acid, 0.5 to 2 percent.</P>
    <P>(e) Sulfur, 3 to 10 percent.</P>
    <P>(f) Sulfur, 3 to 8 percent, when combined with resorcinol or resorcinol monoacetate in accordance with § 333.320.</P>
    <CITA>[75 FR 9776, Mar. 4, 2010]</CITA>
  </SECTION>
</CFRGRANULE>
